Pablo Sánchez-González

Pablo Sánchez-González

Auto-generated profile, based on publicly available information

Pablo Sánchez-González

Clinical Analysis Department, Alicante General University Hospital, Alicante, Spain

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2010 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
PSPablo Sánchez‐González
Pablo Sánchez‐González
KJKarim Jellali
Karim Jellali
AVAntonio Villalobo
Antonio Villalobo

1 January 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
HLHongbing Li
Hongbing Li
SPSvetlana Panina
Svetlana Panina
AKAmandeep Kaur
Amandeep Kaur
MRM.José Ruano
M.José Ruano
PSPablo Sánchez-González
Pablo Sánchez-González
AVAntonio Villalobo
Antonio Villalobo
Calmodulin (CaM) is the major component of calcium signaling pathways mediating the action of various effectors. Transient increases in the intracellular calcium level triggered by a variety of stimuli lead to the formation of Ca(2+)/CaM complexes, which interact with and activate target proteins. In the present study the role of Ca(2+)/CaM in the regulation of the ligand-dependent activation of the epidermal growth factor receptor (EGFR) has been examined in living cells. We show that addition of different cell permeable CaM antagonists to cultured cells or loading cells with a Ca(2+) chelator inhibited ligand-dependent EGFR auto(trans)phosphorylation. This occurred also in the presence of inhibitors of protein kinase C, CaM-dependent protein kinase II and calcineurin, which are known Ca(2+)- and/or Ca(2+)/CaM-dependent EGFR regulators, pointing to a direct effect of Ca(2+)/CaM on the receptor. Furthermore, we demonstrate that down-regulation of CaM in conditional CaM knock out cells stably transfected with the human EGFR decreased its ligand-dependent phosphorylation. Substitution of six basic amino acid residues within the CaM-binding domain (CaM-BD) of the EGFR by alanine resulted in a decreased phosphorylation of the receptor and of its downstream substrate phospholipase Cγ1. These results support the hypothesis that Ca(2+)/CaM regulates the EGFR activity by directly interacting with the CaM-BD of the receptor located at its cytosolic juxtamembrane region.

1 May 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
SPSvetlana Panina
Svetlana Panina
ASAlexander Stephan
Alexander Stephan
JCJonas M. la Cour
Jonas M. la Cour
KJKivin Jacobsen
Kivin Jacobsen
LKLine K. Kallerup
Line K. Kallerup
MBMartin W. Berchtold
Martin W. Berchtold
Calmodulin (CaM) was shown to be essential for survival of lower eukaryotes by gene deletion experiments. So far, no CaM gene deletion was reported in higher eukaryotes. In vertebrates, CaM is expressed from several genes, which encode an identical protein, making it difficult to generate a model system to study the effect of CaM gene deletion. Here, we present a novel genetic system based on the chicken DT40 cell line, in which the two functional CaM genes were deleted and one allele replaced with a CaM transgene that can be artificially regulated. We show that CaM is essential for survival of vertebrate cells as they die in the absence of CaM expression. Reversal of CaM repression or ectopic expression of HA-tagged CaM rescued the cells. Cells exclusively expressing HA-CaM with impaired individual calcium binding domains as well as HA-CaM lacking the ability to be phosphorylated at residues Tyr(99)/Tyr(138) or trimethylated at Lys(115) survived and grew well. CaM mutated at both Ca(2+) binding sites 3 and 4 as well as at both sites 1 and 2, but to a lesser degree, showed decreased ability to support cell growth. Cells expressing CaM with all calcium binding sites impaired died with kinetics similar to that of cells expressing no CaM. This system offers a unique opportunity to analyze CaM structure-function relationships in vivo without the use of pharmacological inhibitors and to analyze the function of wild type and mutated CaM in modulating the activity of different target systems without interference of endogenous CaM.

21 September 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ECErnesto Cortés Castell
Ernesto Cortés Castell
PSPablo Sánchez-González
Pablo Sánchez-González
Antonio Palazón-BruAntonio Palazón-Bru
Antonio Palazón-Bru
VBVicente Bosch-Giménez
Vicente Bosch-Giménez
HMHerminia Manero-Soler
Herminia Manero-Soler
VGVicente F. Gil-Guillen
Vicente F. Gil-Guillen
To analyse the association in newborns between blood levels of phenylalanine and feeding method and gestational age. This observational, cross-sectional study included a sample of 11,829 infants between 2008 and 2013 in a Spanish region. Data were recorded on phenylalanine values, feeding method [breast, formula, mixed (breast plus formula), or partial or fully intravenous feeding], gestational age in weeks (<32, 32–37, ≥37), gender and days since birth at the moment of blood collection. Outcomes were [phenylalanine] and [phenylalanine] ≥95th percentile. Associations were analysed using multivariate models [linear (means difference) and logistic regression (adjusted odds ratios)]. Higher phenylalanine values were associated with lower gestational age (p<0.001) and with intravenous feeding (p<0.001). The degree of prematurity and intravenous feeding influenced the plasma concentration of phenylalanine in the newborn. Caution should be taken in [phenylalanine] for newborns with intravenous feeding, monitoring them carefully. Very preterm infants given the recommended amount of amino acids should also be strictly monitored. These findings should be taken into consideration and call for adapting the amounts to the needs of the infant.